Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276558 · ClinicalTrials.gov registry record · Phase 2
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
A Phase 2 study, sponsored by Recordati Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
NCT04276558 is a Phase 2 study that has completed, run by Recordati Group. The registered enrollment target is 108 participants.
The verdict
NCT04276558, a Phase 2 study, has completed, sponsored by Recordati Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
Study Summary
A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559 in treatment of Neurotrophic Keratitis in Adult Patient in Europe and United States of America.
Interventions
- OTHER Vehicle
- DRUG Udonitrectag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2024-04-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04276558
The ClinicalTrials.gov registry entry for NCT04276558 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Recordati Group, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT04276558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04276558 about?
NCT04276558 is a clinical study titled "REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients". A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559 in treatment of Neurotrophic Keratitis in Adult Patient in Europe and United States of America.
What is the current status of trial NCT04276558?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2020-10-13. Estimated completion is 2024-04-29.
What interventions are being tested in trial NCT04276558?
The interventions under investigation include: Vehicle (OTHER), Udonitrectag (DRUG).
Who is sponsoring clinical trial NCT04276558?
This trial is sponsored by Recordati Group, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.